FoxWare™, An Advanced Data Analysis Package for Hydroxyl Radical Foot-Printing Higher Order Structural Analysis
FoxWare™,一种用于羟基自由基足迹高阶结构分析的高级数据分析包
基本信息
- 批准号:10334462
- 负责人:
- 金额:$ 47.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-01-01 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAdoptedAdoptionAdverse Drug Experience ReportAntibody Binding SitesAppearanceAreaAutomationAwardBindingBinding SitesBiological ProductsBiological Response Modifier TherapyCessation of lifeChemicalsClientComparative StudyComplexComputer softwareConsequentialismCritiquesDangerousnessDataData AnalysesDevelopmentDockingDrug TargetingEnvironmentEpitopesEvaluationGoalsGovernmentGuidelinesHigher Order Chromatin StructureHomeHydroxyl RadicalImmune responseLabelLaboratoriesLasersLettersLigandsLinkLocationManualsMethodsModelingMorbidity - disease rateMorphologic artifactsNaturePatientsPeptidesPharmaceutical PreparationsPharmacologyPhasePlayProcessProductionProtein AnalysisProtein FootprintingProteinsProteomicsReactionResearchResearch PersonnelResolutionRoleSafetySamplingScientistSmall Business Innovation Research GrantStructureTechniquesTechnologyTranslatingUltraviolet RaysVisualizationVisualization softwareWorkadverse drug reactionanalytical toolbiomaterial compatibilitybiopharmaceutical industrycombatcomputerized data processingexperimental studyimprovedinfliximabinterestirritationnew technologyoxidationprocessing speedprogramsprotein protein interactionprotein structureprototyperesearch and developmentsoftware developmenttool
项目摘要
The GenNext Phase II SBIR submssion entitled “FoxWare™, an Advanced Data
Analysis Package for Hydroxyl Radical Foot-printing Higher Order Structural Analysis” is
responsive to the ackowledged need for new and improved tools for higher order
structural analysis (HOS) of biopharmaceuticals. Biopharmaceuticals are complex,
heterogeneous mixtures of 3-dimensional biomolecules, whose safety and efficacy is
reliant upon proper HOS. The presence of proteins with improper HOS has been linked
to severe adverse drug reactions (ADR), establishing the need for new and improved
HOS analytics.
An emerging HOS analysis technique is hydroxyl radical foot-printing (HRPF).
HRPF involves the irreversible labeling of a protein's exterior by reaction with hydroxyl
radicals with subsequent MS analysis to identify the outer portions of the protein. The
most widely used method for generating OH radicals employs a quick burst of UV light,
and is appropriately called fast photochemical oxidation of proteins (FPOP). Academic
laboratories have demonstrated the utility of FPOP for HOS analysis; however adoption
in pharma has been minuscule at best. Guided by the critiques of scientists at leading
biopharmaceutical companies, we have identified barriers that have limited pharma's
adoption of FPOP HRPF. A substantial barrier is the absence of data processing
tools to facilitate HRPF analysis. Today there are no commercial solutions for FPOP
analysis, despite the demonstrated market need for its HOS analytical power.
Today's proteomics data analysis products fail to adequately address specific
work-flow, chemical labeling / artifacts, and comparative study requirements of HRPF
HOS analysis. Researchers are compelled to use a piece-meal approach, arduously
stitching together results from multiple packages and manually manipulating data in
home-brew spreadsheets. As such, data processing represents a significant bottleneck
that greatly complicates and delays progress in HRPF HOS studies. Our FoxWare™
software addresses data processing demands of HRPF HOS analysis. Our proposal
vastly improves HRPF data analysis by replacing laborious and agonizing present-day
practices with an integrated, seamless solution to interpret and amplify the value of
HRPF HOS studies. Upon completion of our envisioned program, FoxWare will make an
indelible mark upon HOS analysis and impart a transformative shift in analytics and
HRPF throughput, addressing the market demands of the biopharmaceutical industry.
GenNext 第二阶段 SBIR 提交的题为“FoxWare™,一种高级数据
用于羟基自由基足迹高阶结构分析的分析包”是
满足对新的和改进的更高阶工具的公认需求
生物制药的结构分析(HOS)。生物制药很复杂,
3维生物分子的异质混合物,其安全性和有效性
依赖适当的居屋。与不适当的 HOS 的蛋白质的存在有关
严重药物不良反应(ADR),确定需要新的和改进的
居屋分析。
一种新兴的 HOS 分析技术是羟基自由基足迹 (HRPF)。
HRPF 涉及通过与羟基反应对蛋白质外部进行不可逆标记
通过随后的 MS 分析来识别自由基,以识别蛋白质的外部部分。这
最广泛使用的产生 OH 自由基的方法采用快速爆发的紫外线,
被恰当地称为蛋白质快速光化学氧化(FPOP)。学术的
实验室已证明 FPOP 在 HOS 分析中的实用性;然而收养
在制药业的影响充其量是微不足道的。以领先科学家的批评为指导
对于生物制药公司,我们已经发现了限制制药公司发展的障碍
采用 FPOP HRPF。一个重大障碍是缺乏数据处理
促进 HRPF 分析的工具。目前 FPOP 还没有商业解决方案
尽管市场对其 HOS 分析能力的需求已得到证实。
当今的蛋白质组数据分析产品无法充分解决特定问题
HRPF 的工作流程、化学标记/工件和比较研究要求
居屋分析。研究人员不得不艰难地采用零敲碎打的方法
将多个包的结果拼接在一起并手动操作数据
自制电子表格。因此,数据处理是一个重大瓶颈
这极大地复杂化并延迟了 HRPF HOS 研究的进展。我们的 FoxWare™
软件满足 HRPF HOS 分析的数据处理需求。我们的建议
通过取代当今费力且痛苦的方法,极大地改进了 HRPF 数据分析
通过集成、无缝的解决方案来解释和放大价值的实践
HRPF 居屋研究。完成我们设想的计划后,FoxWare 将制作一个
居屋分析中不可磨灭的印记,并赋予分析和分析方面的变革性转变
HRPF通量,满足生物制药行业的市场需求。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scot Randy Weinberger其他文献
Scot Randy Weinberger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scot Randy Weinberger', 18)}}的其他基金
Liquid Chromatography Flash Oxidation (LC-Fox™) Protein Footprinting System
液相色谱闪蒸氧化 (LC-Fox™) 蛋白质足迹系统
- 批准号:
10698726 - 财政年份:2023
- 资助金额:
$ 47.08万 - 项目类别:
Multi-Wavelength Fluorescence Radical Dosimetry for Real-Time Assessment of Protein Footprinting Radical Yield
用于实时评估蛋白质足迹自由基产量的多波长荧光自由基剂量测定
- 批准号:
10250755 - 财政年份:2021
- 资助金额:
$ 47.08万 - 项目类别:
In-cell Automated Flash Oxidation (IC-AutoFox™) Protein Footprinting System
细胞内自动闪式氧化 (IC-AutoFox™) 蛋白质足迹系统
- 批准号:
10589128 - 财政年份:2020
- 资助金额:
$ 47.08万 - 项目类别:
In-cell Automated Flash Oxidation (IC-AutoFox™) Protein Footprinting System
细胞内自动闪式氧化 (IC-AutoFox™) 蛋白质足迹系统
- 批准号:
10478371 - 财政年份:2020
- 资助金额:
$ 47.08万 - 项目类别:
In-Cell Radical Dosimetry (ICRD) for improved in vivo Fast Photo-oxidation of Proteins Hydroxyl Radical Protein Footprinting
细胞内自由基剂量测定 (ICRD),用于改善蛋白质体内快速光氧化羟基自由基蛋白质足迹
- 批准号:
10009765 - 财政年份:2020
- 资助金额:
$ 47.08万 - 项目类别:
Software for Determining Proteoform Heterogeneity and Protein Expression Fidelity
用于确定蛋白质异质性和蛋白质表达保真度的软件
- 批准号:
10379422 - 财政年份:2019
- 资助金额:
$ 47.08万 - 项目类别:
Software for Determining Proteoform Heterogeneity and Protein Expression Fidelity
用于确定蛋白质异质性和蛋白质表达保真度的软件
- 批准号:
10257385 - 财政年份:2019
- 资助金额:
$ 47.08万 - 项目类别:
Software for Determining Proteoform Heterogeneity and Protein Expression Fidelity
用于确定蛋白质异质性和蛋白质表达保真度的软件
- 批准号:
10582584 - 财政年份:2019
- 资助金额:
$ 47.08万 - 项目类别:
FoxWare™, An Advanced Data Analysis Package for Hydroxyl Radical Foot-Printing Higher Order Structural Analysis
FoxWare™,一种用于羟基自由基足迹高阶结构分析的高级数据分析包
- 批准号:
10092185 - 财政年份:2018
- 资助金额:
$ 47.08万 - 项目类别:
FoxWare™, An Advanced Data Analysis Package for Hydroxyl Radical Foot-Printing Higher Order Structural Analysis
FoxWare™,一种用于羟基自由基足迹高阶结构分析的高级数据分析包
- 批准号:
9907677 - 财政年份:2018
- 资助金额:
$ 47.08万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 47.08万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 47.08万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 47.08万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 47.08万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 47.08万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 47.08万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 47.08万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 47.08万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 47.08万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 47.08万 - 项目类别:
Research Grant